{"transactions":[{"id":1282238,"issuer":{"id":8505,"kind":"organization","name":"Shuttle Pharmaceuticals Holdings, Inc."},"owners":[{"id":83563,"kind":"person","name":"Brown Milton","position":1,"cik":"0001945206","reported_name":"Brown Milton","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-05T16:55:10.000Z","date":"2024-12-23","kind":"grant","planned":false,"acquired":true,"shares":209790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 209,790 restricted stock units (\"RSUs\") issued to the Reporting Person under the Shuttle Pharmaceuticals Holdings, Inc. 2018 Equity Incentive Plan. The 209,790 RSUs which are scheduled to vest in one third increments on each of 12/31/2025, 12/31/2026 and 12/31/2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (1) 135,785 shares of common stock and (2) 210,832 RSUs, which remain subject to vesting."}],"balance_after":346617,"source":{"system":"sec-edgar","filing":"0001493152-25-005035","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1945206/000149315225005035/ownership.xml","form_type":"5"}},{"id":1696709,"issuer":{"id":8505,"kind":"organization","name":"Shuttle Pharmaceuticals Holdings, Inc."},"owners":[{"id":83563,"kind":"person","name":"Brown Milton","position":1,"cik":"0001945206","reported_name":"Brown Milton","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-02T17:10:30.000Z","date":"2023-12-13","kind":"sale","planned":false,"acquired":false,"shares":2921,"price":0.4632,"value":1353.0072,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by \"sell to cover\" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (i) 1,077,943 shares of common stock and (ii) 16,667 RSUs which remain subject to certain vesting conditions."}],"balance_after":1094610,"source":{"system":"sec-edgar","filing":"0001493152-24-000125","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1945206/000149315224000125/ownership.xml","form_type":"4"}},{"id":2008145,"issuer":{"id":8505,"kind":"organization","name":"Shuttle Pharmaceuticals Holdings, Inc."},"owners":[{"id":83563,"kind":"person","name":"Brown Milton","position":1,"cik":"0001945206","reported_name":"Brown Milton","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-02-17T08:29:02.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Reporting Person received 25,000 stock options (\"Stock Options\") to purchase shares of SHPH common stock on February 15, 2023, which Stock Options vest in full on the first anniversary of the date of grant."}],"balance_after":25000,"derivative":{"exercise_price":1.92,"exercise_date":"2024-02-15","expiration_date":"2028-02-15","underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-23-005375","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1945206/000149315223005375/ownership.xml","form_type":"4"}},{"id":2068727,"issuer":{"id":8505,"kind":"organization","name":"Shuttle Pharmaceuticals Holdings, Inc."},"owners":[{"id":83563,"kind":"person","name":"Brown Milton","position":1,"cik":"0001945206","reported_name":"Brown Milton","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2023-01-04T16:10:37.000Z","date":"2022-12-29","kind":"sale","acquired":false,"shares":995,"price":1.605,"value":1596.975,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 2,702 restricted stock units (\"RSUs\") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by \"sell to cover\" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of 1,072,531 shares of SHPH common stock."}],"balance_after":1072531,"source":{"system":"sec-edgar","filing":"0001493152-23-000318","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1945206/000149315223000318/ownership.xml","form_type":"4"}}]}